Clinical Laserthermia Systems AB announces that the date for conversion of interim shares is estimated to 15 March 2023
Lund, Sweden March 10, 2023 – Clinical Laserthermia Systems AB (“CLS” or the “Company”) can today announce that 25,315,836 new B-shares have been registered with the Swedish Companies Registration Office, as a result of the exercise of warrants of series TO 5 B (“TO 5 B”).Conversion of interim shares to ordinary B-shares takes place around 15 March 2023 and are expected to be available on each subscriber's account around 17 March 2023. The total number of shares in the Company as a result of the warrant exercise of TO 5 B and the directed share issue to underwriters in connection with TO 5